...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: New RVX Tweet
6
Jul 28, 2020 03:46PM
12
Jul 28, 2020 04:26PM
9
Jul 28, 2020 04:54PM
1
Jul 28, 2020 05:23PM
6
Jul 28, 2020 07:30PM
3
Jul 28, 2020 07:56PM
4
Jul 31, 2020 09:44AM
2
Jul 31, 2020 01:31PM
3
Jul 31, 2020 01:49PM
2
Jul 31, 2020 06:14PM
2
Jul 31, 2020 06:16PM
3
Jul 31, 2020 06:33PM
4
Aug 01, 2020 04:22AM

tada, thank you, The data showed remarkable results in reducing inflamed protein biomarkers in patients.

Do we know how many doses of ABL are needed to reduce ACE2 receptors with Type 2?  Complete coverage. How long the effect remains?  Appears ABL is very effective.  Just looking at the effectiveness of ABL in Type 2 patient acquiring COVID.  Some may not have that much time.  

Hopefully the tests have started.  How can one monitor or compare between groups the effectiveness when most COVID patients have different degrees of illness?

Not a scientist, just too many questions.  Thank you all.  This could be RVX's big break. sidebar

 

7
Aug 01, 2020 11:52AM
3
Aug 01, 2020 03:10PM
3
Aug 01, 2020 03:14PM
6
Aug 01, 2020 09:09PM
7
Aug 02, 2020 03:42PM
4
Aug 02, 2020 09:39PM
5
Aug 04, 2020 12:15AM
3
Aug 04, 2020 04:16AM
1
Aug 04, 2020 07:30AM
7
Aug 04, 2020 10:35AM
5
Sep 04, 2020 07:38PM
Share
New Message
Please login to post a reply